Ignite Creation Date:
2025-12-24 @ 1:10 PM
Ignite Modification Date:
2026-03-14 @ 10:59 PM
Study NCT ID:
NCT04735861
Status:
COMPLETED
Last Update Posted:
2024-08-13
First Post:
2021-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma
Sponsor:
Organization: